ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in GLP-1s, oncology, and pipeline strength.

Several pharmaceutical companies have said they will sell drugs directly to patients in the US and offer discounts ...

The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to ...

Donald Trump's announcement regarding the reduction of prices for essential medications, such as those used to combat obesity ...

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 welcomes project leaders, procurement specialists and technical professionals from the whole value chain. On 20-21 April in ...

The CDSCO has made clear there will be no further opportunities for extensions, meaning any units that remain non-compliant ...

President Trump hailed his deal with pharma companies on GLP-1 drug pricing. The question is how big of a difference the deal ...

India's drug regulator is tightening quality control measures, demanding compliance from MSME pharmaceutical manufacturers.